Lixte Biotechnology Holdings, Inc. (LIXT) | Bitcoin Treasury & Ethereum Treasury Stock

#33 Ethereum Treasuries
#140 Bitcoin Treasuries
Lixte Biotechnology Holdings, Inc.
LIXT
$4.87 (0.0%)
Last update 08:00 PM UTC · Jul 24 · NASDAQ
#33 Ethereum Treasuries
Lixte Biotechnology Holdings, Inc.
LIXT
#33 in Ethereum Treasuries
Bitcoin Treasury & Ethereum Treasury Stock · NASDAQ · Pasadena, US
$4.87 (0.0%)
Last update 08:00 PM UTC · Jul 24, 2026
BTC Holdings
11 BTC Treasury
ETH Holdings
301 ETH Treasury
Market Cap
$60.19M
Enterprise Value
$56.75M

Market Overview

Market Cap
$60,192,639
Shares Outstanding
12,359,885
50-Day Moving Average
$6.3
200-Day Moving Average
$4.35
Average Volume (20 Days)
454,939
Beta (5Y)
1.25

Price History

Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG

Lixte Biotechnology Holdings, Inc. Company Overview

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) is a clinical-stage drug discovery company developing biomarker-targeted therapies, particularly inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents, radiation therapy, and immune-checkpoint blockers across cancer indications. Lixte's pipeline includes the LB-100 series, with recent ovarian cancer trial results showing a 40% disease control rate (8/20 patients) when combined with Dostarlimab. The company raised over $11 million via registered direct offerings and private placement, relocated headquarters to Boca Raton, and holds Bitcoin and Ethereum on its corporate balance sheet.

Lixte Biotechnology Holdings, Inc. website url Visit Website Lixte Biotechnology Holdings, Inc. linkedin url Lixte Biotechnology Holdings, Inc. twitter url
Stock Exchange NASDAQ
IPO Date 2007-10-25
Number of Employees 3
Headquarters Pasadena, CA, US

Key Executives

Bastiaan van der Baan

Chief Scientific Officer
Bastiaan van der Baan linkedin Bastiaan van der Baan twitter

Braxten Gorrill

Chief Financial Officer
Braxten Gorrill linkedin Braxten Gorrill twitter

Chris McKay

Chief Operating Officer
Chris McKay linkedin Chris McKay twitter

John Francis Travaglini

CEO & President
John Francis Travaglini linkedin John Francis Travaglini twitter

Peter Stazzone

Chief Financial Officer
Peter Stazzone linkedin Peter Stazzone twitter

Geordan G. Pursglove

Chief Executive Officer, President & Chairman
Geordan G. Pursglove linkedin Geordan G. Pursglove twitter

Featured Posts

View all articles

Press Releases

No press releases found.

SEC Filings

Form Type Filed Accepted Source

LIXT Frequently Asked Questions

As of November 21, 2025, Lixte Biotechnology Holdings, Inc. holds approximately 10.59 BTC as part of its corporate Bitcoin treasury strategy. For more comprehensive insights, you can track LIXT 's Bitcoin holdings on our Bitcoin Treasuries page.

As of November 21, 2025, Lixte Biotechnology Holdings, Inc. holds approximately 300.7 ETH . For more comprehensive insights, you can track LIXT 's Ethereum holdings on our Ethereum Treasuries page.

The current stock price of Lixte Biotechnology Holdings, Inc. (LIXT) is $4.87 as of 08:00 PM UTC · Jul 24, 2026 . For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Lixte Biotechnology Holdings, Inc. (LIXT) includes NOMAD Power Solutions Strengthens Subsidiary Executive Leadership published on July 15, 2026 . For more details and ongoing updates, visit the LIXT news section.